Shannon McKinney-Freeman

Dr. Shannon McKinney-Freeman


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2021 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
TCThomas Clapes
Thomas Clapes
APAikaterini Polyzou
Aikaterini Polyzou
PPPia Prater
Pia Prater
SASagar
Sagar
AMAntonio Morales-Hernández
Antonio Morales-Hernández
ETEirini Trompouki
Eirini Trompouki
Haematopoietic stem cells (HSCs) are normally quiescent, but have evolved mechanisms to respond to stress. Here, we evaluate haematopoietic regeneration induced by chemotherapy. We detect robust chromatin reorganization followed by increased transcription of transposable elements (TEs) during early recovery. TE transcripts bind to and activate the innate immune receptor melanoma differentiation-associated protein 5 (MDA5) that generates an inflammatory response that is necessary for HSCs to exit quiescence. HSCs that lack MDA5 exhibit an impaired inflammatory response after chemotherapy and retain their quiescence, with consequent better long-term repopulation capacity. We show that the overexpression of ERV and LINE superfamily TE copies in wild-type HSCs, but not in Mda5−/− HSCs, results in their cycling. By contrast, after knockdown of LINE1 family copies, HSCs retain their quiescence. Our results show that TE transcripts act as ligands that activate MDA5 during haematopoietic regeneration, thereby enabling HSCs to mount an inflammatory response necessary for their exit from quiescence.

15 February 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
PHPer Holmfeldt
Per Holmfeldt
MGMiguel Ganuza
Miguel Ganuza
HMHimangi Marathe
Himangi Marathe
BHBing He
Bing He
THTrent Hall
Trent Hall
SMShannon McKinney-Freeman
Shannon McKinney-Freeman
Understanding the molecular regulation of hematopoietic stem and progenitor cell (HSPC) engraftment is paramount to improving transplant outcomes. To discover novel regulators of HSPC repopulation, we transplanted >1,300 mice with shRNA-transduced HSPCs within 24 h of isolation and transduction to focus on detecting genes regulating repopulation. We identified 17 regulators of HSPC repopulation: Arhgef5, Armcx1, Cadps2, Crispld1, Emcn, Foxa3, Fstl1, Glis2, Gprasp2, Gpr56, Myct1, Nbea, P2ry14, Smarca2, Sox4, Stat4, and Zfp251. Knockdown of each of these genes yielded a loss of function, except in the cases of Armcx1 and Gprasp2, whose loss enhanced hematopoietic stem cell (HSC) repopulation. The discovery of multiple genes regulating vesicular trafficking, cell surface receptor turnover, and secretion of extracellular matrix components suggests active cross talk between HSCs and the niche and that HSCs may actively condition the niche to promote engraftment. We validated that Foxa3 is required for HSC repopulating activity, as Foxa3−/− HSC fails to repopulate ablated hosts efficiently, implicating for the first time Foxa genes as regulators of HSPCs. We further show that Foxa3 likely regulates the HSC response to hematologic stress. Each gene discovered here offers a window into the novel processes that regulate stable HSPC engraftment into an ablated host.

18 September 2017 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
MGMiguel Ganuza
Miguel Ganuza
THTrent Hall
Trent Hall
DFDavid Finkelstein
David Finkelstein
ACAshley Chabot
Ashley Chabot
GKGuolian Kang
Guolian Kang
SMShannon McKinney-Freeman
Shannon McKinney-Freeman

6 October 2022 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
MGMiguel Ganuza
Miguel Ganuza
THTrent Hall
Trent Hall
JMJacquelyn Myers
Jacquelyn Myers
CNChris Nevitt
Chris Nevitt
RSRaúl Sánchez-Lanzas
Raúl Sánchez-Lanzas
SMShannon McKinney-Freeman
Shannon McKinney-Freeman

10 September 2024 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
TCTerri L. Cain
Terri L. Cain
MDMarta Derecka
Marta Derecka
SMShannon McKinney-Freeman
Shannon McKinney-Freeman

2 May 2019 in Blood
Verified
Journal Article
Closed access
PDF file
MGMiguel Ganuza
Miguel Ganuza
THTrent Hall
Trent Hall
DFDavid Finkelstein
David Finkelstein
YWYong-Dong Wang
Yong-Dong Wang
ACAshley Chabot
Ashley Chabot
SMShannon McKinney-Freeman
Shannon McKinney-Freeman
Although many recent studies describe the emergence and prevalence of 9clonal-hematopoiesis of indeterminate-potential9 (CHIP) in aged human populations, a systematic analysis of the numbers of clones supporting steady-state hematopoiesis throughout mammalian life is lacking. Previous efforts relied on transplantation of 9barcoded9 hematopoietic stem cells (HSC) to track the contribution of HSC clones to reconstituted blood. However, ex vivo manipulation and transplantation alter HSC function and thus may not reflect the biology of steady-state hematopoiesis. Using a non-invasive in vivo color-labeling system, we report the first comprehensive analysis of the changing global clonal complexity of steady-state hematopoiesis during the natural murine lifespan. We observed that the number of clones (i.e. clonal complexity) supporting the major blood and bone marrow hematopoietic compartments decline with age by about 30% and 60%, respectively. Aging dramatically reduced HSC in vivo repopulating activity and lymphoid potential while increasing functional heterogeneity. Continuous challenge of the hematopoietic system by serial transplantation provoked the clonal collapse of both young and aged hematopoietic systems. Whole exome sequencing of serially transplanted aged and young hematopoietic clones confirmed oligoclonal hematopoiesis and revealed mutations in at least 27 genes, including nonsense, missense and deletion mutations in Bcl11b, Hist1h2ac, Npy2r, Notch3, Ptprr and Top2b. Key points The clonal diversity of the hematopoietic system declines with age and after serial transplantation. Aged HSC acquire mutations that might confer a selective advantage during serial transplantation.